PatternsRadar
Sign in

NEULANDLABNeuland Laboratories Limited

NSE
20,642.00INR-460.00 (-2.18%)Close · 20 Nov 2026
3 Nov 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹26,483 CrMarket cap
58.5P/E (TTM)
51.2%Delivery

Filings & corporate actions

74 results filed
CSV
Next results · Q3 FY27
Expected 1 Feb 2027 – 13 Feb 2027
Estimate: filed 32–44 days after quarter end, last 5 times
Dividend
₹34.00 per share · last 24 Jul 2026
2026
  • 3 NovresultsResults · Q2 FY27 · consolidated and standalone+0.8%NSE
  • 12 OctshareholdingShareholding · 30 Sept 2026-1.6%NSE
  • 5 AugresultsResults · Q1 FY27 · consolidated and standalone+8.0%NSE
  • 24 JuldividendDividend · ₹34.00 per share+0.6%
  • 20 JulshareholdingShareholding · 30 Jun 2026+2.8%NSE
  • 12 MayresultsResults · Q4 FY26 · consolidated and standalone-3.0%NSE
  • 11 AprshareholdingShareholding · 31 Mar 2026-2.9%NSE
  • 9 FebresultsResults · Q3 FY26 · consolidated and standalone-2.8%NSE
  • 7 JanshareholdingShareholding · 31 Dec 2025+4.3%NSE

Reaction to results · all yearsrose on day 0 in 25 of 73 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY273 Nov 2026+0.8%+4.0%—3.4×
Q1 FY275 Aug 2026+8.0%+16.3%+14.7%27.0×
Q4 FY2612 May 2026-3.0%-2.2%-0.2%7.8×
Q3 FY269 Feb 2026-2.8%-1.6%-7.6%4.3×
Q2 FY267 Nov 2025+1.5%-2.7%-9.9%10.2×
Q1 FY2631 Jul 2025-2.0%-1.4%+3.4%1.9×
Q4 FY2515 May 2025-6.8%-5.9%+11.2%6.8×
Q3 FY2510 Feb 2025-6.9%-24.8%-25.3%2.9×
Q2 FY256 Nov 2024-10.7%-7.5%+11.0%5.4×
Q1 FY251 Aug 2024+18.1%+22.8%+33.5%13.1×
Q4 FY2410 May 2024-15.1%-12.8%-12.1%4.4×
Q3 FY248 Feb 2024+3.7%+9.5%0.0%2.9×
Q2 FY247 Nov 2023+7.0%+14.9%+10.1%6.0×
Q1 FY243 Aug 2023+5.3%+15.6%+2.1%2.4×
Q4 FY2311 May 2023+1.7%+11.6%+10.7%7.1×
Q3 FY2313 Feb 2023+13.3%+16.3%+19.8%15.9×
Q2 FY2310 Nov 2022+5.7%+6.0%-4.5%9.5×
Q1 FY233 Aug 2022-7.8%-6.5%+3.3%4.3×
Q4 FY2211 May 2022-14.5%-16.2%-13.3%1.6×
Q3 FY221 Feb 2022-5.6%-10.3%-28.0%4.5×
Q2 FY2229 Oct 2021+5.0%+4.8%+9.8%1.4×
Q1 FY223 Aug 2021-5.0%-13.9%-12.4%0.8×
Q4 FY2111 May 2021-10.0%-9.8%-17.7%4.4×
Q3 FY212 Feb 2021+4.3%+44.0%+43.5%2.6×
Q2 FY213 Nov 2020-4.9%-14.4%-13.2%1.5×
Q1 FY214 Aug 2020-8.9%-6.8%+9.2%5.4×
Q4 FY2022 May 2020-5.9%-11.5%+18.8%3.0×
Q3 FY2011 Feb 2020-0.7%-8.9%-33.4%9.8×
Q2 FY2014 Nov 2019-4.4%-9.1%-21.5%11.0×
Q1 FY2013 Aug 2019+5.2%-2.9%+5.6%19.7×
Q4 FY1916 May 2019-6.5%-13.8%-22.6%1.9×
Q3 FY1919 Feb 2019-1.3%+37.6%+19.6%0.1×
Q2 FY194 Dec 2018-1.4%-7.2%+3.7%0.4×
Q1 FY1927 Aug 2018+0.2%+10.2%+0.1%0.2×
Q4 FY1819 Jun 2018+0.2%-2.4%-12.0%1.2×
Q3 FY189 Feb 2018-0.7%+0.9%+0.2%0.4×
Q2 FY1823 Nov 2017-10.8%-23.7%-30.1%2.5×
Q1 FY1822 Sept 2017-4.2%-6.3%+5.3%0.4×
Q4 FY1716 May 20170.0%+7.2%+3.4%0.1×
Q3 FY1711 Feb 2017+1.4%-0.1%+26.8%2.0×
Q2 FY179 Nov 2016-2.3%-5.5%-1.0%1.9×
Q1 FY1713 Aug 20160.0%+14.1%+9.2%1.8×
Q4 FY1623 May 2016-4.4%+2.0%+4.5%0.5×
Q3 FY165 Feb 2016-0.9%-16.2%-14.2%0.5×
Q2 FY166 Nov 2015+3.0%+3.5%+0.9%0.6×
Q1 FY1616 Aug 2015+9.9%-1.5%+36.6%7.3×
Q4 FY158 May 2015+1.3%+2.2%-3.2%0.7×
Q3 FY1531 Jan 2015-20.0%-30.5%-30.8%10.1×
Q2 FY1531 Oct 2014-1.0%-10.5%-7.5%0.4×
Q1 FY151 Aug 2014-3.5%-15.6%+7.9%2.0×
Q4 FY149 May 2014-11.0%-20.2%-6.8%1.9×
Q3 FY146 Feb 2014+0.5%-7.5%-10.8%1.0×
Q2 FY149 Nov 2013+4.2%+7.5%+9.3%3.3×
Q1 FY146 Aug 2013-3.0%+9.1%-7.5%0.1×
Q4 FY1322 May 2013-3.6%-4.9%-10.0%0.4×
Q3 FY1314 Feb 2013-3.8%-9.1%-19.4%0.2×
Q2 FY1320 Nov 2012-4.2%-2.2%-3.1%0.6×
Q1 FY1313 Aug 2012-2.0%+2.6%+27.5%0.6×
Q4 FY124 May 2012+5.0%+8.9%+9.8%0.4×
Q3 FY1210 Feb 2012-3.8%-8.6%-8.6%4.9×
Q2 FY123 Nov 2011-2.6%-8.9%-7.5%0.6×
Q1 FY125 Aug 2011-2.2%-9.2%-12.5%1.0×
Q4 FY1120 May 2011-1.1%-1.6%-2.5%2.5×
Q3 FY112 Feb 2011+5.0%-0.4%+6.8%1.4×
Q2 FY1129 Oct 2010-1.3%-6.8%-18.7%1.2×
Q1 FY1129 Jul 2010-3.1%-3.8%-4.5%0.8×
Q4 FY1029 May 2010-5.7%-8.2%-0.8%0.5×
Q3 FY1028 Jan 2010-4.5%-11.0%-13.0%1.1×
Q2 FY1020 Oct 2009+0.1%-15.8%-17.3%42.2×
Q1 FY1018 Jul 2009-9.4%-15.1%-16.3%3.6×
Q4 FY0921 May 2009+3.4%-4.9%-10.5%8.5×
Q3 FY0922 Jan 2009-11.3%-9.0%-12.3%1.3×
Q2 FY0924 Oct 2008-13.7%+1.4%-3.4%—
Average-2.0%-2.4%-1.8%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY-12.6%
Profit YoY-46.7%
Interest cost YoY+94.8%
Revenue QoQ-29.9%
Profit QoQ-65.0%
CAGR2Y3Y4Y5Y6Y7Y
Revenue+22.9%+16.6%+23.0%+19.4%+18.3%—
Profit+27.2%+19.3%+52.7%+44.0%+50.8%—

Key data

Open21,050.00
Day range20,500.00 – 21,132.00
52-week range11,500.00 – 24,225.00
From 52w high-14.8%
RSI (14)51.1
ATR (14)739.79
Volume37.3K
Avg volume (20D)58.5K
Rel volume0.64×
Volatility (1Y)36.9%
Turnover₹77.8Cr
Traded value (NSE)₹77.8Cr
VWAP20,848.49
SMA 50 / 20020,929.70 / 17,900.98
Price band20%

Delivery percentage

Latest · 20 Nov 202651.2%
20-day avg48.4%
1-year avg39.4%
Percentile (own history)40th
Range6.2–100.0%
Sessions3,560

Over the last 20 sessions NEULANDLAB settled 48.4% of its traded quantity, which is above average for an NSE equity. Its one-year average is 39.4%, so recent sessions are running 9.0 points higher than usual. The latest session ranks higher than 40% of the 3,560 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.16%
Dividend, trailing 12M₹34.00
Paid every year for8 yr
Shareholders49.7K · +12.2% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy106 days ago

Performance returns

1D1W1M3M6M1Y
Price-2.18%-2.07%+9.02%-12.42%+23.68%+18.22%

Valuation

Market cap₹26,483 Cr
Market cap (NSE)₹26,483 Cr
Free-float cap₹17,940 Cr
P/E (TTM)58.5
P/E (NSE)59.8
EPS (TTM)352.73
P/B13.0
Net margin (TTM)19.6%
Other income / PBT6.0%
ROE24.8%
Debt / equity0.17
Shares outstanding1.29Cr
Listed13 Oct 2008

Ownership

Promoter32.26%
Promoter Δ QoQ-0.36 pp
Public67.74%
FII21.93%
DII16.26%
Pledged2.32%

Quarterly results · consolidated

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)439.7776.3641.6449.7
YoY chg+10.5%+136.4%+119.2%-12.6%
Net profit (₹ Cr)40.6212.7147.751.6
YoY chg-60.1%+664.8%+962.4%-46.7%
Net margin9.2%27.4%23.0%11.5%
EPS31.62165.76115.1040.24

Shareholding over time

By quarter

30 Sept 2026 · promoter 32.26% · public 67.74%
30 Sept 2021: promoter 36.22%31 Dec 2021: promoter 36.22%31 Mar 2022: promoter 36.22%30 Jun 2022: promoter 36.22%30 Sept 2022: promoter 36.22%31 Dec 2022: promoter 36.14%31 Mar 2023: promoter 36.14%30 Jun 2023: promoter 36.03%30 Sept 2023: promoter 35.97%31 Dec 2023: promoter 32.80%31 Mar 2024: promoter 32.74%30 Jun 2024: promoter 32.72%30 Sept 2024: promoter 32.64%31 Dec 2024: promoter 32.68%31 Mar 2025: promoter 32.68%30 Jun 2025: promoter 32.68%30 Sept 2025: promoter 32.64%31 Dec 2025: promoter 32.63%31 Mar 2026: promoter 32.63%30 Jun 2026: promoter 32.62%30 Sept 2026: promoter 32.26%
2021-092026-09
  • Promoter
  • Public and others
Promoter
32.26%
Public
67.74%
Promoter change
-0.36 pp
Filed
12 Oct 2026
FII
21.93%
DII
16.26%
Promoter pledged
2.32%

Who the public is

Mutual funds
12.45%

-0.21 pp QoQ

Insurance
1.35%

+0.07 pp QoQ

FPI
21.93%

+0.85 pp QoQ

Retail ≤ ₹2L
15.74%

-0.31 pp QoQ

HNI > ₹2L
6.73%

-0.10 pp QoQ

NRI
1.13%

-0.04 pp QoQ

Bodies corporate
4.82%

+0.15 pp QoQ

Shareholders
49,741

+12.2% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
Davuluri Ownership Trust (Dr. Davuluri Ramamohan Rao, Mr. Davuluri Sucheth Rao and Mr. Davuluri Saharsh Rao - Trustees)Promoter · Other25.98%
MALABAR INDIA FUND LIMITEDFPI4.66%
MUKUL MAHAVIR AGRAWALIndividual3.12%
HDFC MUTUAL FUND - HDFC MNC FUNDMutual fund2.82%
DAVULURI SUCHETH RAOPromoter · Individual2.01%
SIDDHARTH IYERIndividual1.72%
RAMAMOHAN RAO DAVULURIPromoter · Individual1.63%
DAVULURI SAHARSH RAOPromoter · Individual1.60%
HSBC MUTUAL FUND - HSBC SMALL CAP FUNDMutual fund1.55%
ICICI PRUDENTIAL S&P BSE 500 ETFMutual fund1.53%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 24 Jul 2013 CSV
Financial yearPaymentsDeclaredAdjusted
FY2026-271₹34.00₹34.00
FY2025-261₹12.00₹12.00
FY2024-251₹14.00₹14.00
FY2023-241₹10.00₹10.00
FY2022-231₹5.00₹5.00
FY2021-221₹3.00₹3.00
FY2020-211₹2.00₹2.00
FY2019-202₹3.20₹3.20
FY2016-171₹2.00₹2.00
FY2015-161₹1.50₹1.50
FY2014-151₹3.00₹3.00
FY2013-141₹1.20₹1.20
Ex-dateRecord dateDeclaredAdjusted
24 Jul 2026—₹34.00₹34.00
18 Jul 2025—₹12.00₹12.00
12 Jul 2024—₹14.00₹14.00
11 Jul 2023—₹10.00₹10.00
14 Jul 2022—₹5.00₹5.00
29 Jun 2021—₹3.00₹3.00
10 Nov 2020—₹2.00₹2.00
18 Feb 2020—₹2.00₹2.00
27 Jun 2019—₹1.20₹1.20
4 Aug 2016—₹2.00₹2.00
6 Aug 2015—₹1.50₹1.50
16 Jun 2014—₹3.00₹3.00
24 Jul 2013—₹1.20₹1.20

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

52-week highs & lows

Loading…

Each session the stock traded past its previous 52-week high or low, from NSE's daily report; the previous figure is the record it broke. Prices as published, not split-adjusted.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
6.6 years ago
Disclosures on record
44
15 open-market of the newest 44
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
5 Dec 2023Nirupama SundarRelativeSell500₹26.9L5,375.311.0K → 5000.00%0.00 pp7(2)told 5 Dec 2023
30 Sept 2022Payal GuptaRelativeBuy1.3K₹16.2L1,278.12— → 1.3K0.00%7(2)told 30 Sept 2022
1 Sept 2022Nirupama SundarRelativeBuy900₹10.4L1,154.54100 → 1.0K0.00%0.00 pp7(2)told 29 Aug 2022
12 Feb 2021Gannabathula Venkata Krishna Rama RaoPromoterSell1.1K₹22.4L1,950.9743.1K → 42.0K0.33%-0.01 pp7(2)told 12 Feb 2021
12 Feb 2021Gannabathula Veeravenkata SatyanarayanamurthyPromoterSell650₹12.6L1,930.7728.2K → 27.5K0.21%-0.00 pp7(2)told 12 Feb 2021
10 Feb 2021SRINIVASA KRISHNA MOHAN DAVULURIEmployeeSell1.0K₹16.9L1,687.751.0K → —0.00%7(2)told 10 Feb 2021
9 Feb 2021Gannabathula Veeravenkata SatyanarayanamurthyPromoterSell850₹13.3L1,566.1829.0K → 28.2K0.22%-0.01 pp7(2)told 8 Feb 2021
9 Feb 2021Gannabathula Venkata Krishna Rama RaoPromoterSell850₹13.3L1,566.1844.0K → 43.1K0.34%-0.01 pp7(2)told 8 Feb 2021
17 Sept 2020Gannabathula Veeravenkata SatyanarayanamurthyPromoterSell1.0K₹10.5L1,051.3730.5K → 29.5K0.23%-0.01 pp7(2)told 16 Sept 2020
14 Sept 2020Gannabathula Venkata Krishna Rama RaoPromoterSell1.0K₹10.2L1,018.7745.5K → 44.5K0.35%-0.01 pp7(2)told 14 Sept 2020
23 Apr 2020Davuluri Saharsh RaoPromoterBuy9.9K₹29.5L297.532.44L → 2.53L1.97%+0.08 pp7(2)told 20 Mar 2020
31 Mar 2020Davuluri Sucheth RaoPromoterBuy9.5K₹24.8L260.853.28L → 3.38L2.62%+0.07 pp7(2)told 30 Mar 2020
23 Mar 2020Davuluri Sucheth RaoPromoterBuy8.0K₹24.9L310.653.20L → 3.28L2.55%+0.06 pp7(2)told 20 Mar 2020
23 Mar 2020Davuluri Sucheth RaoPromoterBuy9.9K₹29.5L297.532.44L → 2.53L1.97%+0.08 pp7(2)told 20 Mar 2020
23 Mar 2020Davuluri Rama Mohan RaoPromoterBuy25.2K₹74.7L296.5131.78L → 32.03L24.96%+0.20 pp7(2)told 23 Mar 2020

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Filings

CSV
Loading…

Bulk & block deals · 6 Aug 2026

CSV
12 of 41 deals
By year
DateDealClientQuantityPriceValue
6 Aug 2026Buy · bulkHDFC MUTUAL FUND64.5K21,585.00₹139.3Cr
5 Sept 2025Sell · blockAIRAVAT CAPITAL TRUST8.9K14,612.00₹13.0Cr
5 Sept 2025Buy · blockAIRAVAT CAPITAL TRUST II8.9K14,612.00₹13.0Cr
12 Dec 2024Sell · bulkSMALLCAP WORLD FUND INC4.84L15,618.16₹756.6Cr
31 Aug 2023Sell · bulkBNP PARIBAS ARBITRAGE64.9K3,871.31₹25.1Cr
15 May 2023Sell · bulkGRAVITON RESEARCH CAPITAL LLP73.9K2,861.52₹21.2Cr
15 May 2023Buy · bulkGRAVITON RESEARCH CAPITAL LLP73.9K2,858.76₹21.1Cr
15 May 2023Buy · bulkBNP PARIBAS ARBITRAGE70.9K2,898.38₹20.5Cr
11 May 2023Sell · bulkNK SECURITIES RESEARCH PRIVATE LIMITED65.9K2,493.34₹16.4Cr
11 May 2023Buy · bulkNK SECURITIES RESEARCH PRIVATE LIMITED65.8K2,491.99₹16.4Cr
9 Feb 2021Buy · bulkEMPLOYEES RETIREMENT SYSTEM OF TEXAS - SELF MANAGED PORTFOLIO86.0K1,842.24₹15.8Cr
3 Feb 2021Sell · bulkROHINTON SOLI SCREWVALA86.2K1,480.60₹12.8Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.

Exchange surveillance

20 Nov 2026
  • P/E > 50 (4 quarters) · since 2 Nov 2026 — P/E above 50 on the last four quarters’ earnings.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.

Every stock on this session →

Financials · quarterly statement

₹ crore, as filed
By year
 Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27Q2 FY27
Revenue from operations392.8385.0439.6310.8398.0328.4292.8514.3439.7776.3641.6449.7
Other income2.15.44.84.33.97.57.91.88.112.58.57.5
Total income394.9390.4444.4315.2401.9335.8300.6516.1447.8788.7650.1457.2
Total expenses290.4298.2335.2265.8330.0296.5283.0386.6393.3501.2452.2388.2
└ Finance costs3.73.62.71.12.22.34.65.46.87.27.07.3
└ Depreciation15.116.516.316.116.316.920.222.523.925.126.628.8
Profit before tax104.592.2129.849.4127.839.317.6129.454.5287.5197.869.0
Tax expense23.124.632.016.626.211.53.732.613.974.850.217.4
Net profit81.467.697.932.8101.627.813.996.940.6212.7147.751.6
EPS63.4452.6676.2825.6079.1821.6710.8375.4931.62165.76115.1040.24
Net margin20.72%17.55%22.26%10.57%25.52%8.47%4.75%18.83%9.23%27.40%23.02%11.48%
PBT margin26.60%23.95%29.54%15.90%32.10%11.97%6.00%25.17%12.39%37.04%30.84%15.34%
Tax rate22.10%26.72%24.62%33.55%20.49%29.25%20.89%25.17%25.52%26.03%25.36%25.16%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 3 Nov 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Total assets1,579.81,665.11,832.61,943.82,179.92,534.02,930.13,029.6
Current assets760.9833.8921.1952.51,139.51,265.61,483.11,389.9
└ Cash & equivalents45.4125.087.672.5131.941.376.753.7
└ Other bank balances13.711.529.214.5126.915.2278.3396.8
└ Current investments0.00.00.0103.4107.7112.20.00.0
└ Trade receivables361.8324.9373.5305.9315.7440.9541.4294.3
└ Inventories279.2296.3350.4386.5385.8547.9510.3552.1
Total equity994.11,132.81,282.71,395.21,524.81,620.21,874.52,029.7
└ Attributable to owners994.11,132.81,282.71,395.21,524.81,620.21,874.52,029.7
└ Non-controlling interest—0.00.00.00.00.00.00.0
└ Share capital12.912.912.912.912.912.912.912.9
Borrowings121.595.582.594.1136.0160.2196.6342.3
└ Current47.336.837.643.145.371.035.746.0
└ Non-current74.258.744.951.190.789.2160.9296.3
Trade payables171.0178.7192.0222.6252.2289.8269.1208.6
Current liabilities439.0402.8427.7408.9465.7644.3710.2618.6
Total liabilities585.7532.3549.9548.6655.1913.91,055.7999.8
Net debt62.4(41.1)(34.3)(96.2)(230.5)(8.5)(158.4)(108.1)
Debt / equity0.120.080.060.070.090.100.100.17
Current ratio1.732.072.152.332.451.962.092.25

Cash flow, year to date

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Operating cash flow237.2164.9261.2149.4317.4(36.7)346.7361.6
└ Capex(66.1)(42.9)(143.7)(103.5)(206.5)(170.7)(397.1)(260.6)
Free cash flow171.1122.1117.545.9110.9(207.5)(50.5)101.0
Investing cash flow(61.5)(37.8)(149.7)(154.2)(298.2)(52.2)(423.7)(369.9)
Financing cash flow(135.8)(47.5)(69.3)(10.5)25.0(1.9)21.0(14.4)
└ Dividends paid(6.4)(12.8)(12.8)(18.0)(18.0)(15.4)(15.4)(43.6)
└ Buybacks0.00.00.00.00.00.00.00.0
Net change in cash39.979.642.2(15.1)44.4(90.6)(55.3)(23.0)

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

NEULANDLAB at a glance

  • NEULANDLAB closed at ₹20,642 on 20 Nov 2026, -2.18% on the day, +18.2% over one year, 14.8% below its 52-week high of ₹24,225.
  • Delivery was 51.2% of traded quantity on 20 Nov 2026, the 40th percentile of its own 3,560 sessions with a reading (20-session average 48.4%, 1-year average 39.4%).
  • Market capitalisation is ₹26,483 crore at a trailing P/E of 58.5 (trailing EPS ₹352.73).
  • Q2 FY27 results (consolidated, filed 3 Nov 2026): revenue ₹450 crore (-12.6% year on year), net profit ₹52 crore (-46.7%); the price moved +0.8% on the first session after.
  • Promoters held 32.26% at 30 Sept 2026, down 0.36 percentage points on the previous filing, with 2.32% of promoter shares pledged.
  • Q3 FY27 results are expected between 1 Feb 2027 and 13 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE794A01010
SeriesEQ
Listed13 Oct 2008
NSE market cap · 17 Nov 2026₹27,514 Cr
Free-float market cap (NSE)₹18,448 Cr
Shares outstanding (NSE)1.28Cr
History from13 Oct 2008
Sessions4,439
Turnover rank#249

Sector history

  1. to 16 Aug 2026Index industry · Healthcare
  2. from 16 Aug 2026Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

NSE’s own classification, by the snapshot it changed on.

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.